Medicenna Therapeutics (MDNA) PT Lowered to $7 at Maxim Group
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts MDNA Hot Sheet
Price: $0.16 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 2
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 2
Join SI Premium – FREE
Maxim Group analyst Naureen Quibria lowered the price target on Medicenna Therapeutics (NASDAQ: MDNA) to $7.00 (from $9.00) while maintaining a Buy rating.
You May Also Be Interested In
- Amplitude Inc (AMPL) PT Raised to $21 at Needham
- SolarEdge (SEDG) PT Lowered to $31 at Susquehanna
- Qualcomm (QCOM) PT Lowered to $165 at Susquehanna
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
